Form 4: Bausch Health Director John Paulson Acquires Shares in Lieu of Cash Compensation

Director John Paulson acquired 8,967 shares of Bausch Health Companies Inc. in lieu of cash compensation for board service.

Summary

• On June 28, 2024, John Paulson, a director of Bausch Health Companies Inc., acquired 8,967 common shares of the company.
• The acquisition was made in lieu of cash compensation for Paulson's service on the Issuer's Board of Directors for the quarter ending June 30, 2024.
• The price per share was $6.97.
• Following the transaction, Paulson directly owns 252,636 shares.
• The shares were issued as Restricted Share Units, each representing a contingent right to receive one common share of Bausch Health.

Sentiment

Score: 7

Explanation: The sentiment is neutral to slightly positive. The acquisition of shares by a director is generally a good sign, but the amount is relatively small and tied to compensation, so it's not a major event.

Positives

• The acquisition of shares by a director can be seen as a positive sign, indicating confidence in the company's future prospects.

Industry Context

Director share acquisitions are common and often viewed positively, reflecting alignment between management and shareholder interests. This is a standard practice for compensating board members.

Comparison to Industry Standards

• Many companies use stock-based compensation for directors to align their interests with shareholders.
• The amount of shares acquired is relatively small, suggesting it's a routine compensation matter rather than a significant investment decision.
• Comparing this to other pharmaceutical companies, director compensation packages often include a mix of cash and equity.

Stakeholder Impact

• The acquisition of shares by a director could have a slightly positive impact on shareholder sentiment.

Key Dates